Medical Venture Varinos Raises 600 Million Yen in Series C

Accelerating global expansion of "Endometrial Microbiome Test" and R&D of new products Varinos Inc., which develops genetic tests using genomic technology (headquartered in Koto-ku, Tokyo; Yoshiyuki Sakuraba, CEO; Varinos), has raised 600 million yen in a Series C round funding.In addition to existing investors Angel Bridge, SMBC Venture Capital, and Miyako Capital, we have added four new underwriters: Fast Track Initiative, Mitsubishi UFJ Capital, MTG Ventures, and Sony Innovation Fund. This brings the total amount raised to 1.1 billion yen...